Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01118988 |
Recruitment Status
:
Completed
First Posted
: May 7, 2010
Results First Posted
: March 9, 2016
Last Update Posted
: September 30, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Irritable Bowel Syndrome (IBS) Functional Abdominal Pain Fibromyalgia Complex Regional Pain Syndrome (CRPS) Myofacial Pain Chronic Daily Headaches Migraine Headaches Chronic Pain | Behavioral: Mentorship | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 27 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents |
Study Start Date : | December 2009 |
Actual Primary Completion Date : | June 2011 |
Actual Study Completion Date : | June 2011 |
Arm | Intervention/treatment |
---|---|
Experimental: Mentorship
Subjects randomly assigned to this arm received the specified "Mentorship Intervention"
|
Behavioral: Mentorship
Subjects in this condition receive 10 sessions over 8 weeks (2 sessions for the first 2 weeks, 1 session per week for the remaining 6 weeks) with a mentor presenting information on pain self-management and coping techniques, as well as discussing concerns and feelings with the subject receiving the intervention. Information is presented on slides via internet connected home computer. Mentor-mentee interaction is conducted via telephone on a conference call line with a doctoral level psychologist monitoring call for safety of all parties.
Other Names:
|
No Intervention: Control
Subjects randomly assigned to this control group receive treatment as usual (TAU).
|
|
No Intervention: Mentors
Subjects recruited to the "Mentor" arm of the study are UCLA Pediatric Pain Program patients between the ages of 14 and 18. These mentors are identified by the Principal Investigator as children who have not necessarily eliminated pain, but have learned how to cope with pain and maintain appropriate functioning in daily life. Mentors undergo an in depth training from doctoral level psychologists who are members of the research team. Mentors present pain coping information developed by the research team, provide support, and encourage mentees to attend pain management therapies. They are also monitored by doctoral level psychologists throughout the duration of the study to ensure safety and appropriate contact with mentees via telephone.
|
- Adherence to Physician Recommended CAM Therapies [ Time Frame: post intervention (week 8) ]This measure tracks the attendance of CAM therapies recommended by the subjects' pain specialist physician.
- Body Map and Pain Assessment [ Time Frame: 2 months ]
visual depiction of body pain and associated pain ratings over certain periods of time and conditional situations
Range: 0-19 body areas
- Pittsburgh Sleep Quality Index (PSQI) [ Time Frame: 2 months ]
assessment of sleep quality
Range: 0-21; higher scores = lower sleep quality
- Child Symptom Inventory (CSI) [ Time Frame: 2 months ]
Assement of somatic symptom complaints
24 items, range 0-96, higher score = more somatic symptoms
- Child Anxiety Sensitivity Inventory (CASI) - Child Report [ Time Frame: 2 months ]
Assessment of child's anxiety sensitivity
18 items, range 18-54, higher scores = more anxiety sensitivity
- Health Belief Scale (HBS) Short Version - Child Report [ Time Frame: 2 months ]Number of treatment modalities rated 1-4 by participants on the HBS questionnaire, which asked participants to rate how much they think each of 16 listed treatment modalities would help with pain (1=Completely, 2=A lot, 3=Some, 4=A little, 5=Not at all).
- Emotion Regulation Questionnaire (ERQ) - Child Answer [ Time Frame: 2 months ]
assessment of child emotion regulation
Reappraisal subscale: 6 items, range 6-30, higher scores = higher use of reappraisal Suppression subscale: 4 items, range: 4-20, higher scores = higher use of suppression
- Emotion Expression Scale for Children (EESC) [ Time Frame: 2 months ]
assess child emotional expression/emotion regulation
Poor Awareness subscale, 8 items, range: 8-40; higher scores = poorer emotional awareness Expressive Reluctance subscale, 8 items, range: 8-40; higher scores = more expressive reluctance
- Functional Disability Inventory (FDI) [ Time Frame: 2 months ]
assesses functional disability for daily tasks
Range: 0-60; higher scores mean greater functional disability.
- Revised Child Anxiety and Depression Scale (RCADS) Child Report [ Time Frame: 2 months ]
assess levels of symptoms for anxiety disorders and depression
Range: 0-141; Higher scores mean higher symptom level of anxiety and depression
- Beck Depression Inventory 2 (BDI-2) #18 [ Time Frame: baseline, weekly weeks 1-8, 2 months, 4 months ]
assesses suicidal ideation and intent
Number reported is number of participants who reported any level of suicidal ideation or intent at any time and who were followed with the study's emergency protocol to ensure that such participants are not a threat to self or others, and that he/she was under the appropriate mental health care.
- Child Health Questionnaire - Child Report (CHQ) [ Time Frame: 2 months ]
detailed questionnaire about health, daily activites, pain, behavior, family health, self-esteem
Subscales (for all subscales, higher scores = better health):
Behavior - 16 items, averaged, range 1-5 Bodily Pain and Discomfort - 2 items, averaged, range 1-6 Change in Health - 1 item, range 1-5 Family Activities - 6 items, averaged, range 1-5 Family Cohesion - 1 item, range 1-5 Global Health - 1 item, range 1-5 Global Behavior - 1 item, range 1-5 General Health - 12 items, averaged, range 1-5 Mental Health - 16 items, averaged, range 1-5 Physical Functioning - 9 items, averaged, range 1-4 Role/Social Limitations Behavioral - 3 items, range 1-4 Role/Social Limitations Emotional - 3 items, range 1-4 Role/Social Limitations Physical - 3 items, range 1-4 Self-Esteem - 14 items, range 1-5
- Positive and Negative Affect Scale (PANAS) [ Time Frame: 2 months ]
assesses extent to which children have felt a number of positive and negative affects
Positive Affect subscale, 12 items, range: 12-60, higher score = more positive affect Negative Affect subscale, 15 items, range: 15-75, higher score = more negative affect

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Mentors
Inclusion criteria:
- between the ages of 14 and 18
- any patient who has been successfully treated in the UCLA Pediatric Pain Program
- access to telephone
- access to internet enabled computer
Exclusion criteria
- younger than 14
- older than 18
- new patient
- no access to telephone
- no access to internet enabled computer
Mentees and controls:
Inclusion Criteria:
- chronic pain diagnosis
- between the ages of 12 and 17
- access to telephone
- access to internet enabled computer
- new to UCLA Pediatric Pain Clinic
- plans to utilize program CAM therapies
Exclusion Criteria:
- already utilizing UCLA Pediatric Pain Program CAM therapies
- unable to read, speak, or understand english
- younger than 12 or older than 17
- no access to telephone
- no access to internet enabled computer
- not new patient to UCLA Pediatric Pain Clinic
- does not plan to utilize program CAM therapies

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01118988
United States, California | |
UCLA Pediatric Pain Management Clinic | |
Los Angeles, California, United States, 90095 |
Principal Investigator: | Lonnie K. Zeltzer, MD | UCLA Department of Pediatrics |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Lonnie Zeltzer, Distinguished Professor of Pediatrics, Anesthesiology, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles |
ClinicalTrials.gov Identifier: | NCT01118988 History of Changes |
Other Study ID Numbers: |
1R21HD057421-01A2 ( U.S. NIH Grant/Contract ) |
First Posted: | May 7, 2010 Key Record Dates |
Results First Posted: | March 9, 2016 |
Last Update Posted: | September 30, 2016 |
Last Verified: | August 2016 |
Keywords provided by Lonnie Zeltzer, University of California, Los Angeles:
Peer Support Social Support Chronic Pain Behavioral Interventions for Pain Adolescents Children Pediatric |
Mentorship Complementary and Alternative Medicine CAM Pain Pain Management Behavioral |
Additional relevant MeSH terms:
Syndrome Chronic Pain Headache Fibromyalgia Irritable Bowel Syndrome Abdominal Pain Migraine Disorders Complex Regional Pain Syndromes Reflex Sympathetic Dystrophy Headache Disorders Facial Pain Disease Pathologic Processes Pain Neurologic Manifestations |
Nervous System Diseases Signs and Symptoms Muscular Diseases Musculoskeletal Diseases Rheumatic Diseases Neuromuscular Diseases Colonic Diseases, Functional Colonic Diseases Intestinal Diseases Gastrointestinal Diseases Digestive System Diseases Signs and Symptoms, Digestive Headache Disorders, Primary Brain Diseases Central Nervous System Diseases |